Narae Hwang

Dr. Narae Hwang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
NHNarae Hwang
Narae Hwang
ECEunbin Chong
Eunbin Chong
HOHyeonju Oh
Hyeonju Oh
HCHee Won Cho
Hee Won Cho
JLJi Won Lee
Ji Won Lee
SLSoo-Youn Lee
Soo-Youn Lee
Homovanillic acid (HVA) and vanillylmandelic acid (VMA) are end-stage metabolites of catecholamine and are clinical biomarkers for the diagnosis of neuroblastoma. For the first time in Korea, we implemented and validated a liquid chromatography tandem mass spectrometry (LC–MS/MS) assay to measure urinary concentrations of HVA and VMA according to Clinical and Laboratory Standards Institute guidelines. Our LC–MS/MS assay with minimal sample preparation was validated for linearity, lower limit of detection (LOD), lower limit of quantification (LLOQ), precision, accuracy, extraction recovery, carryover, matrix effect, and method comparison. A total of 1209 measurements was performed to measure HVA and VMA in spot urine between October 2019 and September 2020. The relationship between the two urinary markers, HVA and VMA, was analyzed and exhibited high agreement (89.1% agreement, kappa’s k = 0.6) and a strong correlation (Pearson’s r = 0.73). To our knowledge, this is the first study to utilize LC–MS/MS for simultaneous quantitation of spot urinary HVA and VMA and analyze the clinical application of both markers on a large scale for neuroblastoma patients.

22 March 2024 in Clinical Genetics
Verified
Journal Article
Closed access
NHNarae Hwang
Narae Hwang
SKSang-Mi Kim
Sang-Mi Kim
CHChanghee Ha
Changhee Ha
JLJeehun Lee
Jeehun Lee
BCByung‐Ok Choi
Byung‐Ok Choi
Hyung-Doo ParkHyung-Doo Park
Hyung-Doo Park

25 October 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
BLBeomki Lee
Beomki Lee
WHWon Young Heo
Won Young Heo
JKJee Ah Kim
Jee Ah Kim
HLHyun-Seung Lee
Hyun-Seung Lee
NHNarae Hwang
Narae Hwang
PHPh.D.
Ph.D.
Beomki Lee, M.D., Won Young Heo, M.D., Jee Ah Kim, M.D., Hyun-Seung Lee, M.D., Ph.D., Narae Hwang, M.D., Hyung-Doo Park, M.D., Ph.D., Se In Sung, M.D., Ph.D., Yun Sil Chang, M.D., Ph.D., Won Soon Park, M.D., Ph.D., and Soo-Youn Lee, M.D., Ph.D.. Ann Lab Med 2023;43:153-66. https://doi.org/10.3343/alm.2023.43.2.153

28 July 2022 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
PDF file
JKJuhyung Kim
Juhyung Kim
SHSoyoon Hwang
Soyoon Hwang
NHNarae Hwang
Narae Hwang
YLYeonji Lee
Yeonji Lee
HCHee Jeong Cho
Hee Jeong Cho
DBDong Won Baek
Dong Won Baek
Severe chronic neutropenia is classified as severe congenital, cyclic, autoimmune, or idiopathic. However, there is a lot of uncertainty regarding the diagnosis of severe congenital neutropenia (SCN) and chronic idiopathic neutropenia, and this uncertainty affects further evaluations and treatments. A 20-year-old man presented with fever and knee abrasions after a bicycle accident. On admission, his initial absolute neutrophil count (ANC) was 30/µL. He had no medical history of persistent severe neutropenia with periodic oscillation of ANC. Although his fever resolved after appropriate antibiotic therapy, ANC remained at 80/µL. Bone marrow (BM) aspiration and biopsy were performed, and a BM smear showed myeloid maturation arrest. Moreover, genetic mutation test results showed a heterozygous missense variant in exon 4 of the neutrophil elastase ELANE: c597+1G>C (pV190-F199del). The patient was diagnosed with SCN. After discharge, we routinely checked his ANC level and monitored any signs of infection with minimum use of granulocyte colony-stimulating factor (G-CSF), considering its potential risk of leukemic transformation. Considering that SCN can be fatal, timely diagnosis and appropriate management with G-CSF are essential. We report the case of a patient with SCN caused by ELANE mutation who had atypical clinical manifestations. For a more accurate diagnosis and treatment of severe chronic neutropenia, further studies are needed to elucidate the various clinical features of ELANE.

17 October 2019 in Laboratory Medicine
Verified
Journal Article
Closed access
SRSoongki Roh
Soongki Roh
JHJi Yeon Ham
Ji Yeon Ham
KSKyung Eun Song
Kyung Eun Song
NHNarae Hwang
Narae Hwang
NLNan Young Lee
Nan Young Lee
Myeloperoxidase (MPO) deficiency, one of the most common inherited phagocyte defects, and may exist as a transient phenomenon in combination with some clinical condition. Hematological analyzer ADVIA 2120i is used to identify the different types of leukocytes based on their size and staining properties, and by mean peroxidase index (MPXI). When MPO deficiency is present, neutrophils may be incorrectly counted as monocytes with lower MPXI values. We encountered a few cases of MPO deficiency with abnormally high monocytes counts resulting in pseudoneutropenia. These abnormal reports could lead to a mistaken diagnosis of severe neutropenia, which could result in unnecessary therapy. Manual differential count exhibited the normal differential count in every case. Every case yielded a markedly low MPXI value below -20. In conclusion, we suggest that MPO deficiency must be considered in patients especially when abnormally high monocyte counts combined with low MPXI values are observed.